Edward Tobinick MD Blog

Comments: 0

Immediate improvement in stroke pain after treatment by Edward Tobinick, M.D.

Immediate improvements in chronic central post-stroke pain, sensory dysfunction, spasticity, and brain fog after perispinal etanercept treatment by Dr. Tobinick. Filmed on November 19, 2021, at the Institute of Neurological Recovery in Boca Raton, Florida, more than 2 years after stroke.

Request a consultation today

Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use

Posted by INR PLLC on Friday, December 3, 2021 at 3:03 pm
Filed under Blog Posts, Brain Research, INR News, Scientific Publications, Uncategorized · Tagged with #stroke breakthrough, central post-stroke pain, CPSP, Edward Tobinick, Institute of Neurological Recovery, Perispinal Etanercept, Post Stroke Pain, Stroke Recovery, Stroke Rehabilitation, Stroke Treatment, Tobinick

Comments: 0

Neurological improvements after multiple strokes following treatment by Dr. Tobinick

Reduced central post-stroke pain, improved vision and improved sensation after multiple strokes following treatment by Edward Tobinick, M.D. Treatment performed and filmed on October 27, 2021 at the Institute of Neurological Recovery in Boca Raton, Florida.

Request a consultation today

Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use

Posted by INR PLLC on Monday, November 15, 2021 at 4:24 pm
Filed under Blog Posts, Brain Research, INR News, Scientific Publications, Uncategorized · Tagged with #stroke breakthrough, central post-stroke pain, CPSP, Edward Tobinick, Institute of Neurological Recovery, Perispinal Etanercept, Post Stroke Pain, Stroke Recovery, Stroke Rehabilitation, Stroke Treatment, Tobinick

Comments: 0

Improved walking and cognition minutes after treatment by Dr. Tobinick over 5 years after stroke

Improvements in walking and cognition minutes after perispinal etanercept treatment by Edward Tobinick, M.D., at the Institute of Neurological Recovery in Boca Raton, Florida. Treatment performed and filmed on October 5, 2021.

Request a consultation today

Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use

Posted by INR PLLC on Thursday, November 11, 2021 at 3:47 pm
Filed under Blog Posts, Brain Research, INR News, Scientific Publications, Uncategorized · Tagged with #stroke breakthrough, Edward Tobinick, Institute of Neurological Recovery, Perispinal Etanercept, Stroke Recovery, Stroke Rehabilitation, Stroke Treatment, Tobinick

Comments: 0

Neurological improvements following strokes and Long COVID after treatment by Dr. Tobinick

Perispinal etanercept treatment by Edward Tobinick M.D., at the Institute of Neurological Recovery in Boca Raton, Florida. Treatment filmed on October 11, 2021, 11 months after acute COVID-19 infection.

Request a consultation today

Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use

Posted by INR PLLC on Wednesday, October 27, 2021 at 1:27 pm
Filed under Blog Posts, Brain Research, INR News, Scientific Publications, Uncategorized · Tagged with #long COVID, #stroke breakthrough, Edward Tobinick, Institute of Neurological Recovery, Perispinal Etanercept, Stroke Recovery, Stroke Rehabilitation, Stroke Treatment, Tobinick

Comments: 0

Improvement in fine motor (hand) function 2 years after stroke following treatment by Edward Tobinick, M.D.

Improvement in fine motor (hand) function, pain, and sensation 2 years after stroke. Perispinal etanercept treatment by Dr. Tobinick at the Institute of Neurological Recovery® in Boca Raton, Florida, on July 21, 2021.

Request a consultation today

Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use

Posted by INR PLLC on Tuesday, October 5, 2021 at 1:40 pm
Filed under Blog Posts, Brain Research, INR News, Scientific Publications, Uncategorized · Tagged with #stroke breakthrough, Edward Tobinick, Institute of Neurological Recovery, Perispinal Etanercept, Stroke Recovery, Stroke Rehabilitation, Stroke Treatment, Tobinick

About Dr. Tobinick

Edward Lewis Tobinick is an American physician who is the inventor of the perispinal etanercept treatment for chronic stroke pain whose efficacy has been established by a randomized, double-blind, placebo-controlled clinical trial published in January 2020.

Dr. Tobinick graduated Phi Beta Kappa and Magna Cum Laude with honors in biology from Brandeis University in Waltham, Massachusetts and received his M.D. from the University of California San Diego School of Medicine in La Jolla, California.

The published scientific articles documenting unprecedented neurological effects produced by the novel method of drug delivery invented by Dr. Tobinick have been cited by hundreds of scientists from academic centers around the world.

Dr. Tobinick's breakthrough stroke treatment has been used to treat patients from every continent in the world, including from the U.S., Canada, England, Scotland, Wales, Ireland, Mexico, Trinidad, Jamaica, Haiti, Bahamas, Guatemala, Belize, Brazil, Columbia, Bolivia, Uruguay, Ecuador, Chile, Peru, Germany, France, Spain, Italy, Portugal, Belgium, Netherlands, Switzerland, Bulgaria, Romania, Ukraine, Poland, Denmark, Sweden, Norway, Iceland, Gibraltar, Uzbekistan, Turkey, Israel, Saudi Arabia, UAE, Oman, Iraq, Egypt, Morocco, Nigeria, Ghana, Cameroon, South Africa, Mozambique, Kenya, Mauritius, India, Bangladesh, Thailand, Vietnam, China, Hong Kong, Japan, Indonesia, Malaysia, Philippines, Australia, New Zealand, Papua New Guinea, Fiji, and the Cook Islands.

In 2018 the Australian Minister of Health, Hon. Greg Hunt, designated substantial funds to study Dr. Tobinick's breakthrough stroke treatment in Australia.

Dr. Tobinick has been an invited ad hoc reviewer for the journals Brain Research, Clinical Drug Investigation, CNS Drugs, Current Alzheimer Research, Experimental Neurology, Future Neurology, Journal of Neurochemistry, Journal of Neuroimmunology, Neuroscience, and Pharmaceutical Medicine and a member of the Editorial Board of the Journal of Neuroinflammation.

More Info